蒙大拿州 的 肺癌 临床试验
蒙大拿州 有 13 项针对 肺癌 的研究正在招募参与者。
蒙大拿州 的城市
官方研究文本(英文)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- SCL Health - Montana, Billings
- SCL Health - Montana, Billings
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06758401Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Saint Vincent Frontier Cancer Center, Billings
- 以及另外 4 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06498635Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 以及另外 3 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT04267848Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 以及另外 3 项
招募中3 期
70 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06096844Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 以及另外 7 项
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年11月4日 · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 以及另外 3 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月4日 · NCT04181060Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
- Billings Clinic Cancer Center, Billings
- Community Medical Center, Missoula
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月13日 · NCT07393555Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 以及另外 3 项
招募中2 期
18 Minutes · 所有性别 · 更新于 2026年10月9日 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 以及另外 3 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月9日 · NCT06616584Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT05624996Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
招募中观察性研究欢迎健康志愿者
19 至 110 岁 · 所有性别 · 更新于 2026年6月29日 · NCT02012699Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 以及另外 3 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年6月3日 · NCT05642572SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2025年10月28日 · NCT03452774数据来自 ClinicalTrials.gov,检索日期:2026年11月15日。每项研究自行设定入选标准,由研究团队决定谁能参与。